New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 11, 2012
05:55 EDTTHOR, THOR, HTWR, HTWRLeerink's medical devices analyst hosts a meeting
Medical Supplies & Devices Analyst Antalffy, along with Director of the Mechanical Circulatory Support & Heart Failure Device Program at the University of California, Dr. Klein, and Director of the Heart Failure Program at Stanford University Medical Center, Dr. Fowler, hold a discussion entitled, "Debating the Future of LVADs: Long-Term Market Growth Prospects and THOR vs. HTWR" in Palo Alto, California on December 12.
News For THOR;HTWR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
07:40 EDTHTWRHeartWare price target raised to $105 from $90 at Leerink
Subscribe for More Information
February 26, 2015
07:03 EDTHTWRHeartWare reports 737 HeartWave Ventricular Assist Systems sold globally
U.S. revenue, generated through the sale of 382 units during the fourth quarter of 2014, was $41.5 million, a 60% increase from $25.9 million in the fourth quarter of 2013.
07:02 EDTHTWRHeartWare reports Q4 non-GAAP EPS (41c), consensus (59c)
Subscribe for More Information
February 23, 2015
07:28 EDTHTWRHeartWare recall should not have material impact long-term, says Canaccord
Canaccord does not believe the voluntary recall issued by HeartWare should not have any material impact on its business long-term, as the serious event rate is relatively low. The recall pertains to a previously known issue and is in effect a continuation of its 2013 corrective action, Canaccord said. The firm reiterated its Buy rating and $115 price target on HeartWare shares.
February 20, 2015
16:35 EDTHTWRHeartWare issues recall of older HeartWare clinical trial controllers
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use